Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin platelet inhibition during recovery from severe infection
NL-OMON50157Phase 4Active, not recruiting
- Sponsor
- Vrije University Medical Center
- Start
- Jan 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of aspirin in myocardial infarction (MI) (3 arms), sponsored by Vrije University Medical Center. Primary endpoints: PFA-200 closure time, PFA-200 flow slope and 3 more. Started Jan 2018; status: active, not recruiting.
02
Drugs
aspirin
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NL-OMON50157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON50157.